Xiaoyan Ni

653 total citations
31 papers, 491 citations indexed

About

Xiaoyan Ni is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Xiaoyan Ni has authored 31 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Xiaoyan Ni's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaoyan Ni is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaoyan Ni collaborates with scholars based in China, United States and Canada. Xiaoyan Ni's co-authors include Carlos R. Morales, W. Scott Argraves, Guiliang Tang, Kuan‐Chun Huang, Shu‐Wing Ng, Ross S. Berkowitz, William R. Welch, Shu‐Kay Ng, Richard Oko and Dong Choon Park and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Xiaoyan Ni

28 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Ni China 12 198 82 79 71 59 31 491
Chiyi He China 12 201 1.0× 76 0.9× 65 0.8× 31 0.4× 21 0.4× 45 453
Shinji Sato Japan 10 184 0.9× 90 1.1× 98 1.2× 257 3.6× 27 0.5× 28 632
Vivek Dhir United Kingdom 19 607 3.1× 46 0.6× 51 0.6× 80 1.1× 70 1.2× 26 1.0k
Leila Kohan Iran 14 209 1.1× 32 0.4× 34 0.4× 50 0.7× 16 0.3× 41 497
E. Okon Israel 13 172 0.9× 72 0.9× 105 1.3× 50 0.7× 29 0.5× 31 592
María Celia Fernández Canada 11 180 0.9× 105 1.3× 28 0.4× 159 2.2× 25 0.4× 22 525
H Ikegami Japan 12 184 0.9× 69 0.8× 136 1.7× 64 0.9× 23 0.4× 31 583
Xiaoming Wu China 15 303 1.5× 135 1.6× 48 0.6× 16 0.2× 19 0.3× 46 709
Zhaoxia Yang China 8 175 0.9× 79 1.0× 75 0.9× 15 0.2× 28 0.5× 19 474
Yujuan Qi China 12 188 0.9× 56 0.7× 23 0.3× 45 0.6× 16 0.3× 47 395

Countries citing papers authored by Xiaoyan Ni

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Ni more than expected).

Fields of papers citing papers by Xiaoyan Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Ni. The network helps show where Xiaoyan Ni may publish in the future.

Co-authorship network of co-authors of Xiaoyan Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Ni. A scholar is included among the top collaborators of Xiaoyan Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Ni. Xiaoyan Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Huanhuan, Xiaoyan Ni, Guoqiang Cheng, Laishuan Wang, & Jin Wang. (2025). Neonatal osteomyelitis: a case series and literature review. Translational Pediatrics. 14(5). 871–880.
2.
Qian, Xianling, Xiaoyan Ni, Fang Wang, et al.. (2024). Association Between MRI‐Based Radiomics Features and Regional Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma and Its Clinical Outcome. Journal of Magnetic Resonance Imaging. 61(2). 997–1010. 1 indexed citations
3.
Liu, Yang, Xiaoyan Ni, Peng Huang, et al.. (2024). Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma. Abdominal Radiology. 49(8). 2629–2638. 2 indexed citations
4.
Ni, Xiaoyan, et al.. (2023). Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma. Cancer Imaging. 23(1). 15–15. 10 indexed citations
6.
Li, Yubo, et al.. (2023). Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI. Journal of Hepatocellular Carcinoma. Volume 10. 399–411. 5 indexed citations
8.
Huang, Peng, Xiaoyan Ni, Shi Zhang, et al.. (2023). Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm. Journal of Hepatocellular Carcinoma. Volume 10. 169–180. 4 indexed citations
9.
Ni, Xiaoyan, et al.. (2022). Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI. Frontiers in Oncology. 12. 934045–934045. 7 indexed citations
10.
Ni, Xiaoyan, et al.. (2021). MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 975–983. 4 indexed citations
11.
Zhang, Zhiqiang, Ping Xu, Jun Song, et al.. (2020). Recommendations for control and prevention of infections for pediatric orthopedics during the epidemic period of COVID-19. World Journal of Pediatric Surgery. 3(1). e000124–e000124. 5 indexed citations
12.
Ni, Xiaoyan, et al.. (2019). Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis. Frontiers in Oncology. 9. 757–757. 29 indexed citations
13.
Yang, Junzheng, Shu‐Kay Ng, Kuan‐Chun Huang, et al.. (2017). Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. BMC Cancer. 17(1). 422–422. 11 indexed citations
14.
Cao, Jun, et al.. (2017). Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway. Biomedicine & Pharmacotherapy. 96. 450–458. 31 indexed citations
16.
Wang, Yinan, Yao Liu, Chunfang Hu, Xiaoyan Ni, & Xiaobo Huang. (2016). Tumor necrosis factor α-induced protein 8-like 1 promotes apoptosis by regulating B-cell leukemia/lymphoma-2 family proteins in RAW264.7 cells. Oncology Letters. 12(5). 3506–3512. 11 indexed citations
17.
Morales, Carlos R., Andrea L. Marat, Xiaoyan Ni, et al.. (2008). ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. Biochemical and Biophysical Research Communications. 376(3). 472–477. 46 indexed citations
18.
Ni, Xiaoyan & Carlos R. Morales. (2006). The Lysosomal Trafficking of Acid Sphingomyelinase is Mediated by Sortilin and Mannose 6‐phosphate Receptor. Traffic. 7(7). 889–902. 87 indexed citations
19.
Saxena, D.M., Gary K. Yiu, Xiaoyan Ni, et al.. (2004). Characterization of promoter elements involved in the down-regulation of topoisomerase IIα expression in a drug-resistant cell line. Gene. 342(1). 145–155. 5 indexed citations
20.
Zeng, Jibin, et al.. (2004). The trafficking of prosaposin (SGP‐1) and GM2AP to the lysosomes of TM4 sertoli cells is mediated by sortilin and monomeric adaptor proteins. Molecular Reproduction and Development. 68(4). 476–483. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026